VANCOUVER, BC, Jan. 26, 2022 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it will commence trading on the OTCQX® Best Market in the United States when the market opens tomorrow, Thursday, January 27, 2022.


Previous articleatai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments
Next articleMDMA-Assisted Psychotherapy for PTSD: Interviewing Dr. Rachel Yehuda